Technology of Making Tablets
Murat Kizaibek
• Tablets are solid dosage
forms consisting of active
ingredient(s) and suitable
pharmaceutical excipients.
They may vary in size,
shape, weight, hardness,
thickness, disintegration
and dissolution
characteristics, and in other
aspects. They may be
classyfied, according to the
method of manufacture, as
compressed tablets or
molded tablets.
Advantages
• Production aspect
– Large scale production at
lowest cost
– Easiest and cheapest to
package and ship
– High stability
• User aspect (doctor,
pharmacist, patient)
– Easy to handling
– Lightest and most compact
– Greatest dose precision &
least content variability
Disadvantages
• Some drugs resist
compression into dense
compacts
• Drugs with poor wetting, slow
dissolution, intermediate to
large dosages may be difficult
or impossible to formulate and
manufacture as a tablet that
provide adequate or full drug
bioavailability
• Bitter taste drugs, drugs with
an objectionable odor, or
sensitive to oxygen or moisture
may require encapsulation or
entrapment prior to
compression or the tablets
may require coating
Types of tablets
• 1)compressed tablets
• 2)sugar coated tablets
• 3)film coated tablets
• 4)enteric coated tablets
• 5)effervescent tablets
• 6)chewable tablets
• 7)dispersible tablets
• 8)sustained release tablets
• 9)multilayer tablets
• 10)sublingual tablets
• 11)toroches
• 12)buccal tablets
• 13)implant tablets
• 14)hypodermic tablets
• 15)solution tabletc
• 16)vaginal tablets
EXCIPIENTS FOR COMPRESSED
TABLETS
Compressed tablets usually contain a number of
pharmaceutical adjuncts, known as excipients, in addition
to the medicinal substance. The use of appropriate
excipients is important in the development of the optimum
tablets. Excipients determine the bulk of the final product
in dosage forms such as tablet, capsule, etc., the speed
of disintegration, rate of dissolution , release of drug,
protection against moisture, stability during storage, and
compatibility . Excipients should have no bioactivity, no
reaction with the drug substance, no effect on the
functions of other excipients, and no support of
microbiological growth in the product .
A. DILUENTS
Diluents increase the volume to a formulation to
prepare tablets of the desired size. Widely used
fillers are lactose, dextrin, microcrystalline cellu-
lose starch, pregelatinized starch, powdered
sucrose, and calcium phosphate.
• The diluent is selected based on various factors, such as
the experience of the manufacturer in the preparation of
other tablets, its cost, and compatibility with other
formulation ingredients. For example, in the preparation
of tablets or capsules of tetracycline antibiotics, a
calcium salt should not be used as a diluent since
calcium interferes with absorption of the antibiotics from
the GI tract.
B.BINDERS
• Binders promote the adhesion of particles of the
formulation. Such adhesion enables preparation of
granules and maintains the integrity of the final tablet.
As listed in the Table, Commonly used binding agents
include: starch, gelatin and sugars (sucrose, glucose,
dextrose, and lactose).
Examples of Binders
Carboxymethylcellulose, sodium Karaya gum
Cellulose,microcrystalline(Avicel®) Starch, pregelatinized
Ethylcellulose Tragacanth gum
Hydroxypropyl methylcellulose Poly(acrylic acid)
Methylcellulose Polypvinylpyrrolidone
Acacia gum Gelatin
Agar Dextrin
Algin acid Glucose
Guar gum Molasses
C. LUBRICANTS
• Lubricant is a substance capable of reducing or
preventing friction, heat, and wear when introduced as a
film between solid surfaces. It works by coating on the
surface of particles, and thus preventing adhesion of the
tablet material to the dies and punches.
Glycerylmonostearate(USP/NFCH2(OH)CH(OH)CH2O2
CC17H35) is one example of a lubricant. Lubricants play
more than one role in the preparation of tablets as
described below.
• 1. Lubricants improve the flow of granules in the hopper
to the die cavity.
• 2. Lubricants prevent sticking of tablet formulation to the
punches and dies during formulation.
• 3. Lubricants reduce the friction between the tablet and
the die wall during the tablet’s ejection from the tablet
machine.
• 4. Lubricants give a sheen to the finished tablets.
• Commonly used lubricants include: talc,
magnesium stearat, calcium stearate ,stearic
acid, hydrogenated vegetable oils and (PEG).
D. DISINTEGRATORS
• The breakup of the tablets to smaller particles is important for
dissolution of the drug and subsequent bioavailability.
Disintegrators promote such breakup. To rupture or breakup of
tablets, disintegrating agents must swell or expand on exposure to
aqueous solution. Thus, the most effective disintegrating agents in
most tablet systems are those with the highest wa-ter uptake
property. In general, the more hydrophilic, the better disinte-
grating agents are therefore highly hydrophilic. A list of typical
disinte-grants is tabulated in Table
tablet.ppt
E. WETTING AGENTS
• Water molecules attract each other equally in all directions. Water
molecules on the surface, however, can only be pulled into the bulk
water by water molecules underneath, since there are no water
molecules to pull in the opposite direction. The surface tension of
water is strong enough to support the weight of tiny insects such as
water striders. The surface ten-sion in action can be visualized by
placing a small drop of alcohol on a thin layer of water. Alcohol with
lower surface tension mixes with water causing reduction in the
surface tension in the local region. Owing to the higher surface
tension of water in the neighbor, water is pulled from the alcohol
dropped region into the neighbor, and this leads to the formation of a
dry spot in the middle of the water layer.
Compressed tablet manufacture
•The classification of manufacturing methods
wet granulation: suitable for drugs that are stable to moisture
and heat
dry granulation: suitable for drugs that are sensitive to
moisture and heat
powder compression : suitable for drugs that are sensitive
to moisture and heat, fill material possessing, good flowability
and compressibility
granulation
direct
compression
crystal compression:suitable for drugs with proper
crystal form and good flowability
drug
excipients
sieving
adhesive
prilling
dry
processing
granule
lubricant
mix press
wet granulation
dry granulation
drug
excipient
smash sieving mix
press
cake
smash
processing
granule
adhesive
mix press
drugs
excipients
smash sieving mix
adhesive
mix press
powder compression
• crystal compression
drugs
excipients
smash sieving
mix mix press
adhesive
• wet granulation technology
• (一)wet granulation methods and equipment:
• 1.Extrusion grain methods and equipment: first
prescription drug powder and the auxiliary materials
mixed evenly to join adhesive soft material system, then
with soft material compulsory extrusion way through has
a certain size screen hole and granulating method.
wet granulation
Compressed tablet manufacture
—— wet granulation
• The steps of wet granulation
weighing and blending the ingredients(disintegrant)
preparing a damp mass
screening the damp mass into pellets or granules
drying the granulation
sizing the granulation by dry screening
adding lubricant and disintegrant, and blending
tableting by compression
(liquid binder)
Internal(内加法)
External(外加法)
The classification of tablet presses
• Tablet presses:
a. single-punch presses
b. multi-station rotary presses
The main components of single-punch
tablet presses
Core components:
die
lower punch
upper punch
The basic mechanical process of tableting
with single-punch presses
a) filling material
b) scraping away the excessive
granulation
c) forming a tablet by compression
d) pushing up the tablet to stage
surface
e) shoving the tablet aside
A picture of multi-station rotary press
hopper
feed-frame
head: upper turret, lower turret, die table
upper turret
die table
lower turret
tablet.ppt
The core components and compression
cycle of rotary presses
A: upper punch
B: die cavity
C: die
D: lower punch
The compression
is applied by both
the upper punch
and the lower
punch.
The compression cycle of a rotary tablet press
tablet.ppt
Compressed tablet manufacture
—— Direct compression tableting
Suitable for
1) granular chemicals possessing free flowing and
cohesive properties
e.g. potassium chloride
2) chemicals added with special pharmaceutical
excipients which impart the necessary qualities for the
production of tablets by direct compression
The direct compression tableting excipients include:
a) fillers, as spray-dried lactose, microcrystals of alphamonohydrate
lactose, sucroseinvert ,sugar – corn starch mixtures, microcrystalline
cellulose, crystalline malt and dicalcium phosphate;
d) disintegrants, as direct-compression starch, sodium carboxymethyl
starch, cross-linked carboxymethylcellulose fiber, and cross-linked
polyvinylpyrrolidone;
c) lubricants, as magnesium stearate and talc;
d) glidants, fumed silicon dioxide
• Sophora Alopecuruldes L.Seed Tablet
optimization
powder of sophora
AIopecuroides L. Seed
mix 制软材
prilling 、
processing
granule
mix
press
excipient
1%Magnesium
stearate
table 1 the influence of different adhesive to Tablet hardness
formula 1 2 3 4
adhesive 10%
Starch
10%PVP
(water)
10%CMC-Na 10%PVP
(Ethanol)
Hardness
(Kg)
0.68 0.83 0.75 particles
deformed
table 2 the influence of different fillers to Tablet hardness
formula 5 6 7 8
fillers starch Pregelati
nized
starch
lactose 10%PVP
( Ethanol)
Hardnes
s(Kg)
0.68 0.77 3.14 3.55
table 3 factor level
Factor level
A [The amount of Microcrstalline
cellulose(g)]
80 120 160
A [Concentration of PVP
solution(%,g/ml)]
10 15 20
table 4 Result of Orthogonal test
Test NO. A B
A×B Result
1 2 Ⅰ Ⅱ
Total
1
2
3
4
5
6
7
8
9
K1
K2
K3
1
1
1
2
2
2
3
3
3
17.8
24.2
24.4
1
2
3
1
2
3
1
2
3
23.0
21.8
21.6
1
2
3
2
3
1
3
1
2
21.4
22.5
22.5
1
2
3
3
1
2
2
3
1
22.2
22.0
22.2
3.1 2.9 6.0
2.8 3.1 5.9
3.2 2.7 5.9
4.1 4.4 8.5
4.0 4.1 8.1
4.2 3.4 8.5
4.0 3.8 7.8
3.9 4.2 8.1
R×6 6.6 1.4
1.1 0.2
0.6
table5 Analysis of variance table
variance source SS V MS F P
total variance 5.658
A 4.698 2 2.349 33.562 0.0001
B 0.191 2 0.096 1.366 0.3034
A×B 0.139 4 0.035 0.993 0.4077
error 0.630 9 0.070
table6 微晶纤维素用量影响苦豆子片硬度的q检验(n=6)
Comparison
group
两均数之
差 standard
value of q
error
Number
of
group α =0.05 α= 0.01
P
A1andA3 -1.1 0.1074 -10.241 3 4.34 6.33 <0.01
A1andA2 -1.0 0.1074 -9.310 2 3.46 5.24 <0.01
A2andA3 -0.1 0.1074 -9.310 2 3.46 5.24 >0.05
q界值
Tablet coating
The reasons for tablet coating
1) to protect the medicinal agent against destructive exposure to air
and/or humidity;
2) to mask the taste of the drug;
3) to provide special characteristics of drug release;
4) to provide aesthetics or distinction to the product;
5) to prevent inadvertent contact by nonpatients with the drug
substance
The general methods involved in coating tablets are as follows
1) sugarcoating tablets
2) film-coating tablets
3) enteric coating
4) pan coating
5) fluid-bed or air suspension coating
6) compression coating
The sugarcoating of tablets may be divided into the
following steps:
1) waterproofing and sealing (if needed)
2) subcoating
3) smoothing and final rounding
4) finishing and coloring (if desired)
5) polishing
片芯 ——包层隔离——包粉衣层——包糖衣层——包有色糖衣层——打光
film-coating machine
tablet.ppt
tablet.ppt
1) waterproofing and sealing (if needed)
aim: to prevent the components from being adversely
affected by moisture; one or more coats; shellac , zein ,
or a polymer as cellulose acetate phthalate
2) Subcoating aim: to bond the sugar coating to the tablet
and provide rounding
a) 3 to 5 subcoats of a sugar-based syrup are applied.
The sucrose and water syrup also contains gelatin,
acacia, or PVP.
b) When the tablets are partially dry they are sprinkled with
a dusting powder, usually a mixture of powdered sugar
and starch but sometimes talc, acacia, or precipitated
chalk as well.
c) Then drying the tablets. Repetition (15 to 18 times) the
subcoating process until the tablets are of the desired
shape and size.
3) smoothing and final rounding
aim: to complete the rounding and smooth the coatings
5 to 10 additional coatings of a thick syrup; This syrup is
sucrose-based with or without additional components as
starch and calcium carbonate.
4) finishing and coloring
aim: to attain final smoothness and the appropriate color
several coats of a thin syrup containing the desired colorant
5) imprinting
aim: to impart identification codes and other distinctive symbols to the
product
The imprint may be debossed, embossed, engraved, or printed on the
surface with ink.
6) polishing
aim: to render the tablets the desired sheen/gloss/luster
a) pans lined with canvas cloth impregnated with carnauba waxand/or
beeswax
b) Pieces of wax may be placed in a polishing pan
c) light-spraying of the tablets with wax dissolved in a nonaqueous
solvent
Tablet coating
—— film-coating tablets
1) The disadvantages of sugarcoating process
a) time-consuming
b) requiring the expertise of highly skilled technicians
c) doubling the size and weight of the original uncoated tablets
d) may vary in size from batch to batch and within a batch
e) large tablets are not as easily swallowed as are small tablets.
2) The advantages of film-coating process
a) coated tablets having essentially the same weight, shape, and size
as the originally compressed tablet
b) The coating is thin enough to reveal any identifying monograms.
c) far more resistant to destruction by abrasion than are sugar-coated
tablets
d) the coating may be colored to make the tablets attractive and
distinctive.
3) The components of nonaqueous film-coating solutions:
a) film former: e.g. CAP
b) alloying substance: to provide water solubility or permeability to
the film e.g. PEG
c) plasticizer: to render flexibility and elasticity to the coating e.g.
castor oil
d) surfactant: to enhance spreadability of the film e.g.
polyoxyethylene sorbitan derivatives
e) opaquants and colorants: e.g. titanium dioxide, FD&C or D&C
dyes
f) sweeteners, flavors, and aromas: saccharin, vanillin
g) glossant: beeswax
h) volatile solvent: alcohol-acetone mixture
4) The components of a typical aqueous film-coating
solutions:
a) film-forming polymer (7-18%): e.g. cellulose ether
polymers as HPMC, HPC and MC
b) plasticizer (0.5-2.0%): e.g. glycerin, propylene glycol,
PEG, diethyl phthalate, and dibutyl subacetate
c) colorant and opacifier (2.5-8%): FD&C or D&C lakes
and iron oxide pigments
d) water
5) Some problems with aqueous film-coating
a) picking and peeling the appearance of small amounts or large
amounts of film fragments flaking from the tablet surface
b) orange peel effect roughness of the tablet surface due to failure of
spray droplets to coalesce
c) mottling an uneven distribution of color on the tablet surface
d) bridging
filling-in of the score-line or indented logo on the tablet by the film
e) tablet erosion
disfiguration of the core tablet
5) Some problems with aqueous film-coating
a) picking and peeling the appearance of small amounts or large
amounts of film fragments flaking from the tablet surface
b) orange peel effect roughness of the tablet surface due to failure of
spray droplets to coalesce
c) mottling an uneven distribution of color on the tablet surface
d) bridging
filling-in of the score-line or indented logo on the tablet by the film
e) tablet erosion
disfiguration of the core tablet
The reasons for capping,
splitting or laminating of
tablets
1) air entrapment
2) not immaculately cleaned or not perfectly
smoothed punches
3) too great a proportion of fine powder
4) Tablets have aged or have been stored
improperly
quality standards and compendial
requirements
The apparent physical features of compressed tablets:
1) shape: round, oblong, unique 2) thickness: thick or thin
3) diameter: large or small 4) flat or convex
5) unscored or scored in halves, thirds and quadrants
6) engraved or imprinted with an identifying symbol and/or code
number
7) coated or uncoated 8)colored or uncolored 9) number of layer.
The die and punches determine the physical features of compressed
tablets.
quality standards and compendial
requirements
 Other physical specifications and quality standards:
tablet weight weight variation
content uniformity tablet thickness
tablet hardness tablet disintegration
drug dissolution
 in-process controls
 verification after the production
quality standards and compendial requirements
—— tablet weight and Chp weight variation
 Chp weight variation:
sample amount 20 tablets
 Tablets should comply
with the following
requirements stated in
the table below.
Average
weight
Weight
variation
limit
Less than
0.3 g
± 7.5%
0.3 g or
more
± 5%
电子称量仪
quality standards and compendial requirements
—— tablet weight and Chp weight variation
The procedure of weight variation determination in Chp:
Weigh accurately 20 tablets and calculate the average
weight, then weigh individually each of the 20 tablets.
Compare the weight of each tablet with the labelled
tablet (if no labelled weight is stated, compare the weight
of each tablet with the average weight calculated). No
more than 2 of the individual weights exceed the weight
variation limit stated in the table above and none doubles
the limit.
quality standards and compendial requirements
—— tablet hardness and friability
Tablet hardness
1)The greater the pressure applied, the harder the tablets.
2) The hardness required by different tablets
a) lozenges and buccal tablets: hard (dissolve slowly)
b) the tablets for immediate drug release: soft
3) measurement
a) special dedicated hardness testers
b) multifunctional equipment
quality standards and compendial requirements
—— content uniformity
 applys to potent drug of low dose.
 USP method, 10 tablets are individually assayed for their
content.
The amount of active ingredient in each tablet lies within
the range of 85% to 115% of the label claim and the
RSD is less than 6.0%.
quality standards and compendial requirements
—— tablet hardness and friability
(continued)
Friability
1) It is used to determine a tablet’s durability
2) Method: allowing the tablets to roll and fall within the
rotating apparatus (friabilator); determine the loss in
weight;
3) requirement: weight loss ≤1%
硬度检测仪
片剂脆碎度检测仪
溶出仪
tablet.ppt
自动溶出取样机
quality standards and compendial requirements
—— tablet dissolution
1) The importance of in vitro dissolution test
a) to guide the formulation and product development
process toward product optimization
b) to monitor the performance of manufacturing process
c) to assure bioequivalence from batch to batch
d) as a requirement for regulatory approval for product
marketing for products registered with the FDA and
regulatory agencies of other countries.
2) The goal of in vitro dissolution is to provide a
reasonable prediction of the product’s in vivo
bioavailability.
Basis: The combinations of a drug’s solubility and
its intestinal permeability are supposed as a
basis for predicting the likelihood of achieving a
successful in vivo – in vitro correlation (IVIVC).
Considered are drugs determined to have:
a) high solubility and high permeability (IVIVC
may be expected.)
b) low solubility and high permeability (IVIVC
may be expected.)
c) high solubility and low permeability
d) low solubility and low permeability
3) The formulation and manufacturing factors
affecting the dissolution of a tablet
a) the particle size of the drug substance
b) the solubility and hygroscopicity of the
formulation
c) the type and concentration of the disintegrant,
binder, and lubricant used
d) the manufacturing method, particularly, the
compactness of the granulation and the
compression force
e) the in-process variables
4) Test method
a) A volume of the dissolution medium is placed in the
vessel and allowed to come to 37℃±0.5℃.
b) The stirrer is rotate at the specified speed.
c) At stated intervals, samples of the medium are
withdrawn for chemical analysis
5) Requirement for rate of dissolution
The specific required rates of dissolution are different for
tablets containing different medicinal agents.
e.g. not less than 85% of the labeled amount is dissolved
in 30 minutes
6) Inconsistencies in dissolution
occur not between dosage units from the same production
batch, but rather between batches or between products
from different manufacturers.
Pooled dissolution testing has emerged. This process
recognizes the concept of batch characteristics and
allows pooled specimens to be tested.

More Related Content

PPTX
Labeling in pharmaceutical packaging
PPTX
Import of drugs and cosmetic
PPTX
Drugs and magic remedies act
PPTX
Tablet coating defects and their remedies
PDF
Tablet-coating.pdf
PPTX
Pharmacy act, 1948
PPTX
Tablet defects
Labeling in pharmaceutical packaging
Import of drugs and cosmetic
Drugs and magic remedies act
Tablet coating defects and their remedies
Tablet-coating.pdf
Pharmacy act, 1948
Tablet defects

What's hot (20)

PPTX
TABLETS- Coated & uncoated tablet, various modified release tablets
PPTX
Tablet tooling
PPTX
Packaging of pharmaceutical products
PDF
Medicinal and toilet preparations act and rules,1955
PPTX
Parenteral Production process sterilisation and filling
PDF
PRACTICAL MANUAL BASED ON TABLETS
PPTX
Drugs & Cosmetics Act 1940 part III
PDF
Drugs and magic remedies act and rules
PPTX
Parentrals , preparation and evaluation
PDF
MEDICINAL & TOILET PREPARATION ACT
PDF
7. PHARMACEUTICAL PACKAGING.pdf
PPTX
Methods used for the manufacture of tablets
PPTX
Tablet tooling
PPT
Drug and cosmetic act 1940
PPTX
Drugs and cosmetics act, 1940 and rules
PPTX
Granulation ppt
PPTX
Pilot plant scale up for tablets
PPTX
qc test for suppositories.pptx
PPTX
Pharmaceutical Syrup
TABLETS- Coated & uncoated tablet, various modified release tablets
Tablet tooling
Packaging of pharmaceutical products
Medicinal and toilet preparations act and rules,1955
Parenteral Production process sterilisation and filling
PRACTICAL MANUAL BASED ON TABLETS
Drugs & Cosmetics Act 1940 part III
Drugs and magic remedies act and rules
Parentrals , preparation and evaluation
MEDICINAL & TOILET PREPARATION ACT
7. PHARMACEUTICAL PACKAGING.pdf
Methods used for the manufacture of tablets
Tablet tooling
Drug and cosmetic act 1940
Drugs and cosmetics act, 1940 and rules
Granulation ppt
Pilot plant scale up for tablets
qc test for suppositories.pptx
Pharmaceutical Syrup
Ad

Similar to tablet.ppt (20)

PPT
Tablet Manufacturing Technique.ppt
PPTX
All about Tablets (Pharma)
PPT
Tablet formulation ppt
POT
Tablet Formulation Technology
PPTX
Solid dosage forms
PPTX
Tablets formulation
PPTX
Tablet ppt
PPT
Tablets
PPTX
TABLETS.pptx
PPTX
TABLETS.pptx
PPT
23117 copy of oral solid dosage forms
PPTX
Ilmul saidla unani PPT presentation.pptx
PDF
2. Tablets solid dosage forms and manfucturing.pdf
PPTX
Tablets
PPT
Industrial Pharmaceutical Technology
PPTX
U-4 Tablet Compression Physics.pptx
PPT
SOLID DOSAGE FORMS FOR PHARMACY STUDENTS
PPTX
Tablets presentation by darpan kalra
PDF
Pharmacetics 1 tablet Manufacturing PPT.pdf
PPT
23117 copy of oral solid dosage forms
Tablet Manufacturing Technique.ppt
All about Tablets (Pharma)
Tablet formulation ppt
Tablet Formulation Technology
Solid dosage forms
Tablets formulation
Tablet ppt
Tablets
TABLETS.pptx
TABLETS.pptx
23117 copy of oral solid dosage forms
Ilmul saidla unani PPT presentation.pptx
2. Tablets solid dosage forms and manfucturing.pdf
Tablets
Industrial Pharmaceutical Technology
U-4 Tablet Compression Physics.pptx
SOLID DOSAGE FORMS FOR PHARMACY STUDENTS
Tablets presentation by darpan kalra
Pharmacetics 1 tablet Manufacturing PPT.pdf
23117 copy of oral solid dosage forms
Ad

Recently uploaded (20)

PDF
OSCE SERIES - Set 7 ( Questions & Answers ).pdf
PDF
Lecture 8- Cornea and Sclera .pdf 5tg year
PDF
SEMEN PREPARATION TECHNIGUES FOR INTRAUTERINE INSEMINATION.pdf
PPTX
Manage HIV exposed child and a child with HIV infection.pptx
PPTX
09. Diabetes in Pregnancy/ gestational.pptx
PPTX
Acute Coronary Syndrome for Cardiology Conference
PPT
Dermatology for member of royalcollege.ppt
PDF
MNEMONICS MNEMONICS MNEMONICS MNEMONICS s
PPTX
Effects of lipid metabolism 22 asfelagi.pptx
PPT
Infections Member of Royal College of Physicians.ppt
PDF
B C German Homoeopathy Medicineby Dr Brij Mohan Prasad
PPTX
Reading between the Rings: Imaging in Brain Infections
DOCX
PEADIATRICS NOTES.docx lecture notes for medical students
PDF
The Digestive System Science Educational Presentation in Dark Orange, Blue, a...
PPTX
Vaccines and immunization including cold chain , Open vial policy.pptx
PDF
Lecture on Anesthesia for ENT surgery 2025pptx.pdf
PDF
Calcified coronary lesions management tips and tricks
PPTX
Electrolyte Disturbance in Paediatric - Nitthi.pptx
PPTX
Approach to chest pain, SOB, palpitation and prolonged fever
PDF
Comparison of Swim-Up and Microfluidic Sperm Sorting.pdf
OSCE SERIES - Set 7 ( Questions & Answers ).pdf
Lecture 8- Cornea and Sclera .pdf 5tg year
SEMEN PREPARATION TECHNIGUES FOR INTRAUTERINE INSEMINATION.pdf
Manage HIV exposed child and a child with HIV infection.pptx
09. Diabetes in Pregnancy/ gestational.pptx
Acute Coronary Syndrome for Cardiology Conference
Dermatology for member of royalcollege.ppt
MNEMONICS MNEMONICS MNEMONICS MNEMONICS s
Effects of lipid metabolism 22 asfelagi.pptx
Infections Member of Royal College of Physicians.ppt
B C German Homoeopathy Medicineby Dr Brij Mohan Prasad
Reading between the Rings: Imaging in Brain Infections
PEADIATRICS NOTES.docx lecture notes for medical students
The Digestive System Science Educational Presentation in Dark Orange, Blue, a...
Vaccines and immunization including cold chain , Open vial policy.pptx
Lecture on Anesthesia for ENT surgery 2025pptx.pdf
Calcified coronary lesions management tips and tricks
Electrolyte Disturbance in Paediatric - Nitthi.pptx
Approach to chest pain, SOB, palpitation and prolonged fever
Comparison of Swim-Up and Microfluidic Sperm Sorting.pdf

tablet.ppt

  • 1. Technology of Making Tablets Murat Kizaibek
  • 2. • Tablets are solid dosage forms consisting of active ingredient(s) and suitable pharmaceutical excipients. They may vary in size, shape, weight, hardness, thickness, disintegration and dissolution characteristics, and in other aspects. They may be classyfied, according to the method of manufacture, as compressed tablets or molded tablets.
  • 3. Advantages • Production aspect – Large scale production at lowest cost – Easiest and cheapest to package and ship – High stability • User aspect (doctor, pharmacist, patient) – Easy to handling – Lightest and most compact – Greatest dose precision & least content variability
  • 4. Disadvantages • Some drugs resist compression into dense compacts • Drugs with poor wetting, slow dissolution, intermediate to large dosages may be difficult or impossible to formulate and manufacture as a tablet that provide adequate or full drug bioavailability • Bitter taste drugs, drugs with an objectionable odor, or sensitive to oxygen or moisture may require encapsulation or entrapment prior to compression or the tablets may require coating
  • 5. Types of tablets • 1)compressed tablets • 2)sugar coated tablets • 3)film coated tablets • 4)enteric coated tablets • 5)effervescent tablets • 6)chewable tablets • 7)dispersible tablets • 8)sustained release tablets
  • 6. • 9)multilayer tablets • 10)sublingual tablets • 11)toroches • 12)buccal tablets • 13)implant tablets • 14)hypodermic tablets • 15)solution tabletc • 16)vaginal tablets
  • 7. EXCIPIENTS FOR COMPRESSED TABLETS Compressed tablets usually contain a number of pharmaceutical adjuncts, known as excipients, in addition to the medicinal substance. The use of appropriate excipients is important in the development of the optimum tablets. Excipients determine the bulk of the final product in dosage forms such as tablet, capsule, etc., the speed of disintegration, rate of dissolution , release of drug, protection against moisture, stability during storage, and compatibility . Excipients should have no bioactivity, no reaction with the drug substance, no effect on the functions of other excipients, and no support of microbiological growth in the product .
  • 8. A. DILUENTS Diluents increase the volume to a formulation to prepare tablets of the desired size. Widely used fillers are lactose, dextrin, microcrystalline cellu- lose starch, pregelatinized starch, powdered sucrose, and calcium phosphate.
  • 9. • The diluent is selected based on various factors, such as the experience of the manufacturer in the preparation of other tablets, its cost, and compatibility with other formulation ingredients. For example, in the preparation of tablets or capsules of tetracycline antibiotics, a calcium salt should not be used as a diluent since calcium interferes with absorption of the antibiotics from the GI tract.
  • 10. B.BINDERS • Binders promote the adhesion of particles of the formulation. Such adhesion enables preparation of granules and maintains the integrity of the final tablet. As listed in the Table, Commonly used binding agents include: starch, gelatin and sugars (sucrose, glucose, dextrose, and lactose).
  • 11. Examples of Binders Carboxymethylcellulose, sodium Karaya gum Cellulose,microcrystalline(Avicel®) Starch, pregelatinized Ethylcellulose Tragacanth gum Hydroxypropyl methylcellulose Poly(acrylic acid) Methylcellulose Polypvinylpyrrolidone Acacia gum Gelatin Agar Dextrin Algin acid Glucose Guar gum Molasses
  • 12. C. LUBRICANTS • Lubricant is a substance capable of reducing or preventing friction, heat, and wear when introduced as a film between solid surfaces. It works by coating on the surface of particles, and thus preventing adhesion of the tablet material to the dies and punches. Glycerylmonostearate(USP/NFCH2(OH)CH(OH)CH2O2 CC17H35) is one example of a lubricant. Lubricants play more than one role in the preparation of tablets as described below.
  • 13. • 1. Lubricants improve the flow of granules in the hopper to the die cavity. • 2. Lubricants prevent sticking of tablet formulation to the punches and dies during formulation. • 3. Lubricants reduce the friction between the tablet and the die wall during the tablet’s ejection from the tablet machine. • 4. Lubricants give a sheen to the finished tablets.
  • 14. • Commonly used lubricants include: talc, magnesium stearat, calcium stearate ,stearic acid, hydrogenated vegetable oils and (PEG).
  • 15. D. DISINTEGRATORS • The breakup of the tablets to smaller particles is important for dissolution of the drug and subsequent bioavailability. Disintegrators promote such breakup. To rupture or breakup of tablets, disintegrating agents must swell or expand on exposure to aqueous solution. Thus, the most effective disintegrating agents in most tablet systems are those with the highest wa-ter uptake property. In general, the more hydrophilic, the better disinte- grating agents are therefore highly hydrophilic. A list of typical disinte-grants is tabulated in Table
  • 17. E. WETTING AGENTS • Water molecules attract each other equally in all directions. Water molecules on the surface, however, can only be pulled into the bulk water by water molecules underneath, since there are no water molecules to pull in the opposite direction. The surface tension of water is strong enough to support the weight of tiny insects such as water striders. The surface ten-sion in action can be visualized by placing a small drop of alcohol on a thin layer of water. Alcohol with lower surface tension mixes with water causing reduction in the surface tension in the local region. Owing to the higher surface tension of water in the neighbor, water is pulled from the alcohol dropped region into the neighbor, and this leads to the formation of a dry spot in the middle of the water layer.
  • 18. Compressed tablet manufacture •The classification of manufacturing methods wet granulation: suitable for drugs that are stable to moisture and heat dry granulation: suitable for drugs that are sensitive to moisture and heat powder compression : suitable for drugs that are sensitive to moisture and heat, fill material possessing, good flowability and compressibility granulation direct compression crystal compression:suitable for drugs with proper crystal form and good flowability
  • 20. dry granulation drug excipient smash sieving mix press cake smash processing granule adhesive mix press
  • 22. • crystal compression drugs excipients smash sieving mix mix press adhesive
  • 23. • wet granulation technology • (一)wet granulation methods and equipment: • 1.Extrusion grain methods and equipment: first prescription drug powder and the auxiliary materials mixed evenly to join adhesive soft material system, then with soft material compulsory extrusion way through has a certain size screen hole and granulating method.
  • 25. Compressed tablet manufacture —— wet granulation • The steps of wet granulation weighing and blending the ingredients(disintegrant) preparing a damp mass screening the damp mass into pellets or granules drying the granulation sizing the granulation by dry screening adding lubricant and disintegrant, and blending tableting by compression (liquid binder) Internal(内加法) External(外加法)
  • 26. The classification of tablet presses • Tablet presses: a. single-punch presses b. multi-station rotary presses
  • 27. The main components of single-punch tablet presses Core components: die lower punch upper punch
  • 28. The basic mechanical process of tableting with single-punch presses a) filling material b) scraping away the excessive granulation c) forming a tablet by compression d) pushing up the tablet to stage surface e) shoving the tablet aside
  • 29. A picture of multi-station rotary press hopper feed-frame head: upper turret, lower turret, die table upper turret die table lower turret
  • 31. The core components and compression cycle of rotary presses A: upper punch B: die cavity C: die D: lower punch The compression is applied by both the upper punch and the lower punch. The compression cycle of a rotary tablet press
  • 33. Compressed tablet manufacture —— Direct compression tableting Suitable for 1) granular chemicals possessing free flowing and cohesive properties e.g. potassium chloride 2) chemicals added with special pharmaceutical excipients which impart the necessary qualities for the production of tablets by direct compression
  • 34. The direct compression tableting excipients include: a) fillers, as spray-dried lactose, microcrystals of alphamonohydrate lactose, sucroseinvert ,sugar – corn starch mixtures, microcrystalline cellulose, crystalline malt and dicalcium phosphate; d) disintegrants, as direct-compression starch, sodium carboxymethyl starch, cross-linked carboxymethylcellulose fiber, and cross-linked polyvinylpyrrolidone; c) lubricants, as magnesium stearate and talc; d) glidants, fumed silicon dioxide
  • 35. • Sophora Alopecuruldes L.Seed Tablet optimization
  • 36. powder of sophora AIopecuroides L. Seed mix 制软材 prilling 、 processing granule mix press excipient 1%Magnesium stearate
  • 37. table 1 the influence of different adhesive to Tablet hardness formula 1 2 3 4 adhesive 10% Starch 10%PVP (water) 10%CMC-Na 10%PVP (Ethanol) Hardness (Kg) 0.68 0.83 0.75 particles deformed
  • 38. table 2 the influence of different fillers to Tablet hardness formula 5 6 7 8 fillers starch Pregelati nized starch lactose 10%PVP ( Ethanol) Hardnes s(Kg) 0.68 0.77 3.14 3.55
  • 39. table 3 factor level Factor level A [The amount of Microcrstalline cellulose(g)] 80 120 160 A [Concentration of PVP solution(%,g/ml)] 10 15 20
  • 40. table 4 Result of Orthogonal test Test NO. A B A×B Result 1 2 Ⅰ Ⅱ Total 1 2 3 4 5 6 7 8 9 K1 K2 K3 1 1 1 2 2 2 3 3 3 17.8 24.2 24.4 1 2 3 1 2 3 1 2 3 23.0 21.8 21.6 1 2 3 2 3 1 3 1 2 21.4 22.5 22.5 1 2 3 3 1 2 2 3 1 22.2 22.0 22.2 3.1 2.9 6.0 2.8 3.1 5.9 3.2 2.7 5.9 4.1 4.4 8.5 4.0 4.1 8.1 4.2 3.4 8.5 4.0 3.8 7.8 3.9 4.2 8.1 R×6 6.6 1.4 1.1 0.2 0.6
  • 41. table5 Analysis of variance table variance source SS V MS F P total variance 5.658 A 4.698 2 2.349 33.562 0.0001 B 0.191 2 0.096 1.366 0.3034 A×B 0.139 4 0.035 0.993 0.4077 error 0.630 9 0.070
  • 42. table6 微晶纤维素用量影响苦豆子片硬度的q检验(n=6) Comparison group 两均数之 差 standard value of q error Number of group α =0.05 α= 0.01 P A1andA3 -1.1 0.1074 -10.241 3 4.34 6.33 <0.01 A1andA2 -1.0 0.1074 -9.310 2 3.46 5.24 <0.01 A2andA3 -0.1 0.1074 -9.310 2 3.46 5.24 >0.05 q界值
  • 43. Tablet coating The reasons for tablet coating 1) to protect the medicinal agent against destructive exposure to air and/or humidity; 2) to mask the taste of the drug; 3) to provide special characteristics of drug release; 4) to provide aesthetics or distinction to the product; 5) to prevent inadvertent contact by nonpatients with the drug substance
  • 44. The general methods involved in coating tablets are as follows 1) sugarcoating tablets 2) film-coating tablets 3) enteric coating 4) pan coating 5) fluid-bed or air suspension coating 6) compression coating
  • 45. The sugarcoating of tablets may be divided into the following steps: 1) waterproofing and sealing (if needed) 2) subcoating 3) smoothing and final rounding 4) finishing and coloring (if desired) 5) polishing
  • 50. 1) waterproofing and sealing (if needed) aim: to prevent the components from being adversely affected by moisture; one or more coats; shellac , zein , or a polymer as cellulose acetate phthalate 2) Subcoating aim: to bond the sugar coating to the tablet and provide rounding a) 3 to 5 subcoats of a sugar-based syrup are applied. The sucrose and water syrup also contains gelatin, acacia, or PVP.
  • 51. b) When the tablets are partially dry they are sprinkled with a dusting powder, usually a mixture of powdered sugar and starch but sometimes talc, acacia, or precipitated chalk as well. c) Then drying the tablets. Repetition (15 to 18 times) the subcoating process until the tablets are of the desired shape and size.
  • 52. 3) smoothing and final rounding aim: to complete the rounding and smooth the coatings 5 to 10 additional coatings of a thick syrup; This syrup is sucrose-based with or without additional components as starch and calcium carbonate. 4) finishing and coloring aim: to attain final smoothness and the appropriate color several coats of a thin syrup containing the desired colorant
  • 53. 5) imprinting aim: to impart identification codes and other distinctive symbols to the product The imprint may be debossed, embossed, engraved, or printed on the surface with ink. 6) polishing aim: to render the tablets the desired sheen/gloss/luster a) pans lined with canvas cloth impregnated with carnauba waxand/or beeswax b) Pieces of wax may be placed in a polishing pan c) light-spraying of the tablets with wax dissolved in a nonaqueous solvent
  • 54. Tablet coating —— film-coating tablets 1) The disadvantages of sugarcoating process a) time-consuming b) requiring the expertise of highly skilled technicians c) doubling the size and weight of the original uncoated tablets d) may vary in size from batch to batch and within a batch e) large tablets are not as easily swallowed as are small tablets.
  • 55. 2) The advantages of film-coating process a) coated tablets having essentially the same weight, shape, and size as the originally compressed tablet b) The coating is thin enough to reveal any identifying monograms. c) far more resistant to destruction by abrasion than are sugar-coated tablets d) the coating may be colored to make the tablets attractive and distinctive.
  • 56. 3) The components of nonaqueous film-coating solutions: a) film former: e.g. CAP b) alloying substance: to provide water solubility or permeability to the film e.g. PEG c) plasticizer: to render flexibility and elasticity to the coating e.g. castor oil d) surfactant: to enhance spreadability of the film e.g. polyoxyethylene sorbitan derivatives e) opaquants and colorants: e.g. titanium dioxide, FD&C or D&C dyes f) sweeteners, flavors, and aromas: saccharin, vanillin g) glossant: beeswax h) volatile solvent: alcohol-acetone mixture
  • 57. 4) The components of a typical aqueous film-coating solutions: a) film-forming polymer (7-18%): e.g. cellulose ether polymers as HPMC, HPC and MC b) plasticizer (0.5-2.0%): e.g. glycerin, propylene glycol, PEG, diethyl phthalate, and dibutyl subacetate c) colorant and opacifier (2.5-8%): FD&C or D&C lakes and iron oxide pigments d) water
  • 58. 5) Some problems with aqueous film-coating a) picking and peeling the appearance of small amounts or large amounts of film fragments flaking from the tablet surface b) orange peel effect roughness of the tablet surface due to failure of spray droplets to coalesce c) mottling an uneven distribution of color on the tablet surface d) bridging filling-in of the score-line or indented logo on the tablet by the film e) tablet erosion disfiguration of the core tablet
  • 59. 5) Some problems with aqueous film-coating a) picking and peeling the appearance of small amounts or large amounts of film fragments flaking from the tablet surface b) orange peel effect roughness of the tablet surface due to failure of spray droplets to coalesce c) mottling an uneven distribution of color on the tablet surface d) bridging filling-in of the score-line or indented logo on the tablet by the film e) tablet erosion disfiguration of the core tablet
  • 60. The reasons for capping, splitting or laminating of tablets 1) air entrapment 2) not immaculately cleaned or not perfectly smoothed punches 3) too great a proportion of fine powder 4) Tablets have aged or have been stored improperly
  • 61. quality standards and compendial requirements The apparent physical features of compressed tablets: 1) shape: round, oblong, unique 2) thickness: thick or thin 3) diameter: large or small 4) flat or convex 5) unscored or scored in halves, thirds and quadrants 6) engraved or imprinted with an identifying symbol and/or code number 7) coated or uncoated 8)colored or uncolored 9) number of layer. The die and punches determine the physical features of compressed tablets.
  • 62. quality standards and compendial requirements  Other physical specifications and quality standards: tablet weight weight variation content uniformity tablet thickness tablet hardness tablet disintegration drug dissolution  in-process controls  verification after the production
  • 63. quality standards and compendial requirements —— tablet weight and Chp weight variation  Chp weight variation: sample amount 20 tablets  Tablets should comply with the following requirements stated in the table below. Average weight Weight variation limit Less than 0.3 g ± 7.5% 0.3 g or more ± 5%
  • 65. quality standards and compendial requirements —— tablet weight and Chp weight variation The procedure of weight variation determination in Chp: Weigh accurately 20 tablets and calculate the average weight, then weigh individually each of the 20 tablets. Compare the weight of each tablet with the labelled tablet (if no labelled weight is stated, compare the weight of each tablet with the average weight calculated). No more than 2 of the individual weights exceed the weight variation limit stated in the table above and none doubles the limit.
  • 66. quality standards and compendial requirements —— tablet hardness and friability Tablet hardness 1)The greater the pressure applied, the harder the tablets. 2) The hardness required by different tablets a) lozenges and buccal tablets: hard (dissolve slowly) b) the tablets for immediate drug release: soft 3) measurement a) special dedicated hardness testers b) multifunctional equipment
  • 67. quality standards and compendial requirements —— content uniformity  applys to potent drug of low dose.  USP method, 10 tablets are individually assayed for their content. The amount of active ingredient in each tablet lies within the range of 85% to 115% of the label claim and the RSD is less than 6.0%.
  • 68. quality standards and compendial requirements —— tablet hardness and friability (continued) Friability 1) It is used to determine a tablet’s durability 2) Method: allowing the tablets to roll and fall within the rotating apparatus (friabilator); determine the loss in weight; 3) requirement: weight loss ≤1%
  • 74. quality standards and compendial requirements —— tablet dissolution 1) The importance of in vitro dissolution test a) to guide the formulation and product development process toward product optimization b) to monitor the performance of manufacturing process c) to assure bioequivalence from batch to batch d) as a requirement for regulatory approval for product marketing for products registered with the FDA and regulatory agencies of other countries.
  • 75. 2) The goal of in vitro dissolution is to provide a reasonable prediction of the product’s in vivo bioavailability. Basis: The combinations of a drug’s solubility and its intestinal permeability are supposed as a basis for predicting the likelihood of achieving a successful in vivo – in vitro correlation (IVIVC).
  • 76. Considered are drugs determined to have: a) high solubility and high permeability (IVIVC may be expected.) b) low solubility and high permeability (IVIVC may be expected.) c) high solubility and low permeability d) low solubility and low permeability
  • 77. 3) The formulation and manufacturing factors affecting the dissolution of a tablet a) the particle size of the drug substance b) the solubility and hygroscopicity of the formulation c) the type and concentration of the disintegrant, binder, and lubricant used d) the manufacturing method, particularly, the compactness of the granulation and the compression force e) the in-process variables
  • 78. 4) Test method a) A volume of the dissolution medium is placed in the vessel and allowed to come to 37℃±0.5℃. b) The stirrer is rotate at the specified speed. c) At stated intervals, samples of the medium are withdrawn for chemical analysis 5) Requirement for rate of dissolution The specific required rates of dissolution are different for tablets containing different medicinal agents. e.g. not less than 85% of the labeled amount is dissolved in 30 minutes
  • 79. 6) Inconsistencies in dissolution occur not between dosage units from the same production batch, but rather between batches or between products from different manufacturers. Pooled dissolution testing has emerged. This process recognizes the concept of batch characteristics and allows pooled specimens to be tested.